1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Andrew McDonald: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer Flibanserin 100 MG, Placebo, Androgen deprivation therapy - Prostate Adenocarcinoma | Phase 2 | Completed | Andrew McDonald | 44 | 2021-07-02 | 2026-07-20 |
Androgen Antagonists (1) · flibanserin (1)
United States (1)
R21CA259808 (1)